A study on the interaction of crotapotin with crotoxin phospholipase A2, notexin and other presynaptic neurotoxins.
1 Crotapotin, the acidic subunit of crotoxin, greatly potentiated the presynaptic effect of isolated basic phospholipase A (PLA) of crotoxin in both mouse diaphragm and chick biventer cervicis muscles whereas the myotoxic effect was not affected significantly.2 In contrast to crotoxin PLA, the presynaptic effects of notexin and notechis-5, self-active single chain toxins, were antagonized by crotapotin while actions of beta-bungarotoxin were not affected.3 By assaying PLA activity, crotoxin PLA was found to be unstable in physiological salt solution, especially when in contact with muscle, due to massive non-specific binding to and destruction by the muscle.4 The decline of crotoxin PLA was greatly reduced by the presence of crotapotin but not by another acidic protein, volvatoxin A(2), or heparin.5 Notechis-5 was found to be stable even when in the presence of muscles.6 [(3)H]-acetylated crotoxin PLA, which retained about 40% of its original enzyme and presynaptic blocking activities, also bound rapidly to the mouse diaphragm on incubation and this binding was greatly hindered by the simultaneous addition of crotapotin.7 The prevention of binding of crotoxin PLA by crotapotin occurred mostly at those sites where the binding was easily dissociable on washing. No antagonism of binding occurred at the firmly binding site.8 The binding of [(3)H]-acetylated crotapotin was much less than that of crotoxin PLA, and interestingly, the binding was increased by the latter, suggesting that crotapotin may be first bound to the diaphragm together with crotoxin PLA.9 No specific binding at the endplate zone was found either for crotoxin PLA or for crotapotin.10 It is concluded that crotapotin potentiates the presynaptic effect of crotoxin PLA by curtailing its non-specific affinity with muscles, minimizing its dispersal and destruction en route to the nerve terminal, but not by acting as an affinity probe for the nerve terminal.
D000818:Animals; D002645:Chickens; D003439:Crotoxin / Q000494:pharmacology; D004347:Drug Interactions; D004355:Drug Stability; D004546:Elapid Venoms / Q000494:pharmacology; D066298:In Vitro Techniques; D051379:Mice; D009119:Muscle Contraction; D009469:Neuromuscular Junction / Q000187:drug effects*; D009498:Neurotoxins / Q000494:pharmacology*; D010741:Phospholipases A / Q000494:pharmacology; D054467:Phospholipases A2
D004546:Elapid Venoms; D009498:Neurotoxins; C005082:notexin; D003439:Crotoxin; D010741:Phospholipases A; D054467:Phospholipases A2